{
  "author": {
    "name": "Adam C Farkas Esq",
    "webUrl": "/author/profile/adam-c-farkas-esq/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2022/06/15/pbms-could-be-driving-up-plan-sponsors-drug-costs/",
        "title": "PBMs could be driving up plan sponsors' drug costs",
        "byline": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, and Adam C.  Farkas, Esq. ",
        "kicker": "",
        "prettyDate": "June 15, 2022",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/06/AdobeStock_2105272583.jpg",
          "width": "750",
          "height": "500"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jonathan-e-levitt-esq-dae-y-lee-pharmd-esq-cpbs/",
            "name": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS,"
          },
          {
            "webUrl": "/author/profile/adam-c-farkas-esq/",
            "name": "Adam C.  Farkas, Esq. "
          }
        ],
        "kickerNode": [],
        "summary": "Far too many pharmacy benefit managers (PBMs) thrive on opacity in their business operations, but sometimes public litigation shines the light of day on secretive practices.",
        "body": null
      }
    ]
  }
}